| |
Acute surgery
|
Elective surgery
| |
|---|
|
Type of surgery
|
n (%)a
|
Median suPAR
|
90-days mortality: n (%)
|
n
|
Median suPAR
|
90-days mortality: n (%)
|
p-value suPARb
|
p-value mortalityc
|
|---|
|
Gastroenterological
|
353 (68.7)
|
3.7
|
75 (21.3)
|
161
|
3.2
|
9 (5.6)
|
0.0032
|
< 0.0001
|
|
Orthopedic
|
320 (57.7)
|
4.3
|
61 (19.1)
|
235
|
2.8
|
5 (2.1)
|
< 0.0001
|
< 0.0001
|
|
Cardiothoracic
|
111 (30.3)
|
2.8
|
8 (7.2)
|
255
|
2.6
|
3 (1.2)
|
0.16
|
0.0041d
|
|
Neurological
|
68 (44.7)
|
2.9
|
8 (11.8)
|
84
|
2.8
|
2 (2.4)
|
0.90
|
0.043d
|
|
Respiratory
|
357 (86.9)
|
4.4
|
131 (36.7)
|
54
|
3.1
|
5 (9.3)
|
< 0.0001
|
< 0.0001
|
|
Urological
|
87 (41.6)
|
4.4
|
14 (16.1)
|
122
|
3.1
|
5 (4.1)
|
< 0.0001
|
0.0029
|
|
Minor
|
381 (87.0)
|
4.5
|
114 (29.9)
|
57
|
3.8
|
4 (7.0)
|
0.065
|
0.0003
|
|
Endoscopies
|
764 (76.7)
|
4.2
|
145 (19.0)
|
230
|
3.3
|
11 (4.8)
|
< 0.0001
|
< 0.0001
|
|
Gynecological
|
34 (34.7)
|
2.8
|
1 (2.9)
|
64
|
2.7
|
0
|
0.53
|
0.17
|
|
Obstetrics
|
231 (89.1)
|
1.6
|
0
|
28
|
1.8
|
0
|
0.50
| |
|
Vascular
|
54 (36.7)
|
4.1
|
12 (22.2)
|
93
|
4.2
|
1 (1.1)
|
0.96
|
< 0.0001
|
|
Dermatological
|
161 (80.5)
|
4.1
|
29 (18.0)
|
39
|
3.7
|
1 (2.6)
|
0.022
|
0.0153d
|
|
Other
|
10 (10.5)
|
2.5
|
1 (10.0)
|
85
|
2.8
|
2 (2.4)
|
0.71
|
0.19
|
|
Cancer-relatede
|
104 (40.5)
|
4.1
|
46 (44.2)
|
153
|
3.4
|
11 (7.2)
|
0.010
|
< 0.0001
|
- suPAR soluble urokinase plasminogen activator receptor
- aThe percentage of total surgery in the specific specialty
- bp-value is calculated for suPAR in acutely vs. electively operated patients
- cp-value is calculated for acute 90-day mortality compared with elective 90-day mortality
- dFisher’s exact test is used instead of Pearson’s Chi-squared test
- eCancer-related surgery is measured as the patient having cancer as the main diagnosis when surgery was performed
